tiprankstipranks
MediWound announces results from comparison of EscharEx vs SANTYL
PremiumThe FlyMediWound announces results from comparison of EscharEx vs SANTYL
2M ago
MediWound to Participate in Two Upcoming Investor Conferences
PremiumPress Releases
MediWound to Participate in Two Upcoming Investor Conferences
2M ago
MediWound price target raised to $28 from $26 at H.C. Wainwright
PremiumThe Fly
MediWound price target raised to $28 from $26 at H.C. Wainwright
3M ago
MediWound announces peer-review publication of EscharEx
PremiumThe FlyMediWound announces peer-review publication of EscharEx
4M ago
MediWound Announces Peer-Reviewed Publication of EscharEx® Mechanism of Action Study Assessing Its Effects on Biofilm and Microbial Loads
PremiumPress Releases
MediWound Announces Peer-Reviewed Publication of EscharEx® Mechanism of Action Study Assessing Its Effects on Biofilm and Microbial Loads
4M ago
MediWound appoints Hess as Chief Operating Officer, Chief Commercial Officer
PremiumThe Fly
MediWound appoints Hess as Chief Operating Officer, Chief Commercial Officer
5M ago
MediWound to Report Third Quarter 2023 Financial Results
PremiumPress ReleasesMediWound to Report Third Quarter 2023 Financial Results
5M ago
MediWound receives positive CHMP opinion on NexoBrid in pediatric patients
PremiumThe Fly
MediWound receives positive CHMP opinion on NexoBrid in pediatric patients
5M ago
MediWound Receives Positive CHMP Opinion Recommending Approval for NexoBrid® to Treat Pediatric Patients
PremiumPress Releases
MediWound Receives Positive CHMP Opinion Recommending Approval for NexoBrid® to Treat Pediatric Patients
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100